These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 10703150)

  • 21. [Effect of low-density lipoprotein apheresis on the complement system in patients with hereditary hypercholesterolemia].
    Bokchubaev ET; Kukharchuk VV; Nasonov EL; Konovalov GA; Masenko VP
    Klin Med (Mosk); 1992; 70(9-10):45-8. PubMed ID: 1474811
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasma-exchange therapy of homozygous familial hypercholesterolemia.
    King ME; Breslow JL; Lees RS
    N Engl J Med; 1980 Jun; 302(26):1457-9. PubMed ID: 7374711
    [No Abstract]   [Full Text] [Related]  

  • 23. Low density lipoprotein apheresis in pediatric patients with homozygous familial hypercholesterolemia.
    Coker M; Ucar SK; Simsek DG; Darcan S; Bak M; Can S
    Ther Apher Dial; 2009 Apr; 13(2):121-8. PubMed ID: 19379151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [LDL-apheresis in Sardinia, Italy].
    Pintus P
    G Ital Nefrol; 2012; 29 Suppl 54():S19-21. PubMed ID: 22388824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia.
    Drouin-Chartier JP; Tremblay AJ; Bergeron J; Lamarche B; Couture P
    Circulation; 2017 Aug; 136(9):880-882. PubMed ID: 28847800
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia.
    Stefanutti C; Di Giacomo S; Vivenzio A; Isacchi GC; Masella R; Caprari P; Varì R; Tarzia A; Mosiello A; Cantafora A
    Clin Sci (Lond); 2001 Feb; 100(2):191-8. PubMed ID: 11171288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of LDL apheresis on restenosis after angioplasty.
    Kanemitsu S; Tekekoshi N; Murakami E
    Chem Phys Lipids; 1994 Jan; 67-68():339-43. PubMed ID: 8187232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of severe hypercholesterolemia by heparin-induced extracorporeal LDL precipitation (HELP).
    Schuff-Werner P; Armstrong VW; Eisenhauer T; Thiery J; Seidel D
    Beitr Infusionsther; 1988; 23():118-26. PubMed ID: 2484765
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term experience with the HELP system for treatment of severe familial hypercholesterolemia.
    Eisenhauer T; Schuff-Werner P; Armstrong VW; Talartschik J; Scheler F; Seidel D
    ASAIO Trans; 1987; 33(3):395-7. PubMed ID: 3675971
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of plasmafractionation filters and filtration techniques in the clinical practice of LDL-apheresis.
    Kochinke F; Baeyer HV; Schwaner I; Schwerdtfeger R
    ASAIO Trans; 1986; 32(1):388-91. PubMed ID: 3778740
    [No Abstract]   [Full Text] [Related]  

  • 31. The use of combined LDL affinity apheresis utilizing dextran sulfate cellulose columns and hypolipidemic medications in patients with severe hypercholesterolemia to assess regression of atherosclerosis.
    Jones PH
    Beitr Infusionsther; 1988; 23():142-5. PubMed ID: 2484769
    [No Abstract]   [Full Text] [Related]  

  • 32. Regression of atherosclerosis in patients with familial hypercholesterolaemia under LDL-apheresis.
    Borberg H; Gaczkowski A; Hombach V; Oette K; Stoffel W
    Prog Clin Biol Res; 1988; 255():317-26. PubMed ID: 3340643
    [No Abstract]   [Full Text] [Related]  

  • 33. Low-density lipoprotein apheresis therapy with a direct hemoperfusion column: a Japanese multicenter clinical trial.
    Tasaki H; Yamashita K; Saito Y; Bujo H; Daida H; Mabuchi H; Tominaga Y; Matsuzaki M; Fukunari K; Nakazawa R; Tsuji M; Kawade Y; Yamamoto S; Ueda Y; Takayama K
    Ther Apher Dial; 2006 Feb; 10(1):32-41. PubMed ID: 16556134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical applications of long-term LDL-apheresis on and beyond refractory hypercholesterolemia.
    Mabuchi H; Higashikata T; Kawashiri MA
    Transfus Apher Sci; 2004 Jun; 30(3):233-43. PubMed ID: 15172629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia.
    Miltiadous G; Saougos V; Cariolou M; Elisaf MS
    Ann Clin Lab Sci; 2006; 36(3):353-5. PubMed ID: 16951279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pattern of red blood cells and platelets cholesterol and fatty acids in homozygous familial hypercholesterolemic patients treated with LDL-apheresis.
    Stefanutti C; Lucani G; Vivenzio A; Di Giacomo S; Lucani E; Mazzarella B
    Clin Ter; 1998; 149(3):231-3. PubMed ID: 9842108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is lipoprotein (a)-apheresis useful?
    Bambauer R
    Ther Apher Dial; 2005 Apr; 9(2):142-7. PubMed ID: 15828926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Selective apheresis of low-density lipoproteins].
    Griskevicius A; Audzijoniene J
    Medicina (Kaunas); 2006; 42(6):499-503. PubMed ID: 16816545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [LDL-apheresis: current status].
    Stefanutti C; Vivenzio A; Lucani G; Di Giacomo S
    Clin Ter; 2001; 152(1):65-9. PubMed ID: 11382172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case with homozygote familial hypercholesterolemia treated with LDL apheresis and coronary bypass in adolescence period].
    Altinel E; Cetinkaya S; Kara C; Orün UA; Aydin H; Kutsal A
    Anadolu Kardiyol Derg; 2008 Jun; 8(3):231-2. PubMed ID: 18524734
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.